- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bridge Biotherapeutics Inc (288330)
Bridge Biotherapeutics Inc stock price live, this page displays KQ 288330 stock exchange data. View the 288330 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bridge Biotherapeutics Inc real time stock price chart below.
What Is the Bridge Biotherapeutics Inc Stock Price Today?
The Bridge Biotherapeutics Inc stock price today is 2,900.
What Is the Stock Symbol for Bridge Biotherapeutics Inc?
The stock symbol for Bridge Biotherapeutics Inc is ""288330.""
What Stock Exchange Does Bridge Biotherapeutics Inc Trade On?
Bridge Biotherapeutics Inc is listed and trades on the KOSDAQ stock exchange.
Is Bridge Biotherapeutics Inc a Good Stock to Buy?
Determining whether Bridge Biotherapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 288330 quote. (ISIN: KR7288330004)
What Is the Bridge Biotherapeutics Inc Stock Price Today?
The Bridge Biotherapeutics Inc stock price today is 2,900.
What Is the Stock Symbol for Bridge Biotherapeutics Inc?
The stock symbol for Bridge Biotherapeutics Inc is ""288330.""
What Stock Exchange Does Bridge Biotherapeutics Inc Trade On?
Bridge Biotherapeutics Inc is listed and trades on the KOSDAQ stock exchange.
Is Bridge Biotherapeutics Inc a Good Stock to Buy?
Determining whether Bridge Biotherapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 288330 quote. (ISIN: KR7288330004)
KOSDAQ
Currency in KRW
2,900
-65(-2.19%)
Closed·
Fair Value
An estimate of a Bridge Bio's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,855
3,120
52 wk Range
671
9,280
288330 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
288330 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Bridge Bio's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,8553,120
52 wk Range
6719,280
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
288330 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Bridge Bio's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Bridge Biotherapeutics Inc Company Profile
Bridge Biotherapeutics, Inc., a clinical stage biotech company, engages in the development of therapeutics for the treatment of ulcerative colitis, fibrotic diseases, and cancers worldwide. Its products in pipeline includes BBT-401, a Pellino-1 inhibitor, which is in Phase I clinical trial for the treatment of ulcerative colitis; and BBT-877, an autotaxin inhibitor that is in Phase I clinical trial for the treatment of various fibrotic diseases, such as idiopathic pulmonary fibrosis. Bridge Biotherapeutics, Inc. has a research collaboration with Atomwise to launch small molecule programs across various therapeutic areas using structure-based AI technology for drug discovery; the University of Colorado School of Medicine to explore the potential of BBT-877 for immuno-oncology; and the Emory University School of Medicine to explore combination therapy of BBT-877 for KRAS/P53 mutant NSCLC patients resistant to anti-PD-1 blockade. The company was founded in 2015 and is headquartered in Seongnam, Korea.
Compare 288330 to Peers and Sector
Metrics to compare | 288330 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship288330PeersSector | |
|---|---|---|---|---|
P/E Ratio | −12.7x | −8.3x | −0.5x | |
PEG Ratio | −0.21 | 0.00 | 0.00 | |
Price/Book | 11.0x | 2.7x | 2.6x | |
Price / LTM Sales | 21,968.4x | 5.8x | 3.3x | |
Upside (Analyst Target) | - | 0.0% | 42.8% | |
Fair Value Upside | Unlock | 15.4% | 6.5% | Unlock |
Earnings
Latest Release
May 14, 2025
EPS / Forecast
-96.00 / --
Revenue / Forecast
9.00M / --
People Also Watch
FAQ
What Stock Exchange Does Bridge Bio Trade On?
Bridge Bio is listed and trades on the KOSDAQ stock exchange.
What Is the Stock Symbol for Bridge Bio?
The stock symbol for Bridge Bio is "288330."
What Is the Bridge Bio Market Cap?
As of today, Bridge Bio market cap is 240.18B.
What Is Bridge Bio's Earnings Per Share (TTM)?
The Bridge Bio EPS (TTM) is -428.51.
From a Technical Analysis Perspective, Is 288330 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Bridge Bio Stock Split?
Bridge Bio has split 2 times.
How Many Employees Does Bridge Bio Have?
Bridge Bio has 35 employees.
What is the current trading status of Bridge Bio (288330)?
As of 06 Aug 2025, Bridge Bio (288330) is trading at a price of 2,900.00, with a previous close of 2,965.00. The stock has fluctuated within a day range of 2,855.00 to 3,120.00, while its 52-week range spans from 671.00 to 9,280.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.